Cen­tu­ry Ther­a­peu­tics boosts iP­SC man­u­fac­tur­ing space in New Jer­sey as part of com­pa­ny wide ex­pan­sion

It’s been a busy few years for Penn­syl­va­nia-based Cen­tu­ry Ther­a­peu­tics since it burst on­to the scene with a $250M fund­ing haul in sum­mer 2019. Now, the biotech is scal­ing up its man­u­fac­tur­ing ca­pac­i­ty as part of a com­pa­ny­wide foot­print build­out.

Cen­tu­ry has leased 53,000 square feet of space in Branch­burg, New Jer­sey, for a new man­u­fac­tur­ing fa­cil­i­ty for its in­duced pluripo­tent stem cell ther­a­pies. That build­out is part of a larg­er ex­pan­sion that will in­clude ex­pand­ed lab and cor­po­rate space in Philadel­phia.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.